(Q44512688)

3 December 2017

Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women (English)

1 reference

Hormone Replacement Therapy

3 December 2017

1 reference

1

1 reference

3 December 2017

2

Olavi Ylikorkala

1 reference

3 December 2017

Matti J Tikkanen

3

1 reference

PubMed ID

12860228

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

American Journal of Cardiology

3 December 2017

1 reference

3 December 2017

92

1 reference

3 December 2017

2

1 reference

3 December 2017

212-214

1 reference

Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Evidence from randomised trials on the long-term effects of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Effect of statins on C-reactive protein in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Coronary atherogenic risk factors in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900542-3

10.1016/S0002-9149(03)00542-3

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

12860228